{
    "nctId": "NCT01018251",
    "briefTitle": "Positron Emission Tomography in Monitoring Treatment Response in Women With Newly Diagnosed Breast Cancer",
    "officialTitle": "Monitoring Treatment Response in Women With Breast Cancer Utilizing FLT-PET/CT",
    "overallStatus": "WITHDRAWN",
    "conditions": "Adult Women With a New Diagnosis of Invasive Breast Cancer (Have Not Undergone Treatment)",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Sensitivity and specificity of FLT-PET comparing with standard FDG-PET",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast biopsy positive for an invasive malignancy (core needle, mammatone, or incisional biopsy)\n* Participants must be planning to have surgery at the Hospital of the University of Pennsylvania\n* Participants must be able to tolerating lying on the table for about an hour\n* Newly diagnosed primary breast cancer, which is classified as being operable (T1-T4)\n\nExclusion Criteria:\n\n* Pregnant women\n* History of severe renal disease\n* Prior history of breast cancer of the study breast within the last five years.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}